Table 1.
Proportions of patients with p53, Ki-67 and thymidiylate synthase (TS) overexpression in groups with differing outcomes following liver resection, showing actual survival and actual disease-free survival
| Variable | Earlya death, n | Longtermb survivors, n | P-value (χ2 test) | Earlya recurrence, n | Longtermb disease-free survivors, n | P-value (χ2 test) |
|---|---|---|---|---|---|---|
| p53 | 19/29 | 12/29 | 0.113 | 34/59 | 8/16 | 0.777 |
| Ki-67 | 6/29 | 11/29 | 0.248 | 12/59 | 7/16 | 0.101 |
| TS | 24/29 | 19/29 | 0.230 | 43/59 | 12/16 | 1.000 |
a
Within 2 years.
b
Over 5 years.